1,2-Bis(1,1,2,2-tetrafluoroethoxy)benzene, 97.0%, 25g

2-(2-(2-(2-(4-Nitrophenoxy)ethoxy)ethoxy)ethoxy)ethyl 4-methylbenzenesulfonate, 98%, 250mg

NHS C3 azides, ≥95%, 5 mg, plastic packaging.

(S)-1-(4-Bromothiophen-2-yl)ethanamine hydrochloride, 98%, 1g

cyclopentyl 2-(3,5-dimethylphenyl)ethyl ketone, 97.0%, 1g

2-(4-Morpholinophenyl)acetic acid, 98%, 5g

Ethyl 1-(5-fluoropyridin-2-yl)piperidine-4-carboxylate, 95%, 1g

(R)-Styrene Oxide>96.0%(GC)5g

2-AMINO-N-(2-METHOXYPHENYL)ACETAMIDE, 95.0%, 250mg

2-(2-Cyclopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98.0%, 1g

2-methyl-4-(trifluoromethyl)-2,7-dihydro-6H-pyrazolo[3,4-b]pyridin-6-one, 10g

4-Amino-2-methoxyphenol, 97.0%, 1g

6-Hydroxy-2-phenylpyridazin-3(2H)-one, 95.0%, 5g